Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes

Introduction Gestational Diabetes Mellitus (GDM) development is related to underlying metabolic syndrome that is associated with elevated complement C3 and C4. Elevated C3 levels have been associated with preeclampsia and the development of macrosomia. Methods This case-control study included 34 pregnant women with GDM and 16 non-diabetic (ND) women in their second trimester. Complement-related proteins were measured and correlated with demographic, biochemical, and pregnancy outcome data. Results GDM women were older with a higher BMI (p<0.001); complement C3, C4 and Factor-H were significantly elevated (p=0.001, p=0.05, p=0.01, respectively). When adjusted for age and BMI, Complement C3 (p=0.04) and Factor-H (p=0.04) remained significant. Partial correlation showed significant correlation between C4 with serum alanine aminotransferase (ALT) (p<0.05) and 2nd term diastolic blood pressure (p<0.05); Factor-H and C-reactive protein (CRP; p<0.05). Pearson bivariate analysis revealed significant correlations between C3, C4, and Factor-H and CRP; p<0.05; C3 and gestational age at delivery (GA; p<0.05); C4 and ALT and second-trimester systolic blood pressure (STBP) (p=0.008 and p<0.05, respectively); Factor-H and glycated hemoglobin (HbA1c) (p<0.05). Regression analysis showed that the elevation of C3 could be accounted for by age, BMI, GA and CRP, with CRP being the most important predictor (p=0.02). C4 elevation could be accounted for by ALT, CRP and STBP. CRP predicted Factor-H elevation. Conclusion The increased C3, C4 and Factor-H during the second trimester of pregnancy in GDM are not independently associated with GDM; inflammation and high BMI may be responsible for their elevation. The elevation of second trimester C3 in GDM is associated with earlier delivery and further work is needed to determine if this is predictive.

[1]  K. Gurpreet,et al.  updated overview , 2022, International journal of health sciences.

[2]  S. M. Lee,et al.  Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia , 2020, Journal of Korean medical science.

[3]  U. Wenzel,et al.  The role of complement in arterial hypertension and hypertensive end organ damage , 2020, British journal of pharmacology.

[4]  Z. Mo,et al.  Elevated C-reactive protein and complement C3 levels are associated with preterm birth: a nested case–control study in Chinese women , 2020, BMC Pregnancy and Childbirth.

[5]  Cain C. T. Clark,et al.  The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose–response meta-analysis of observational studies , 2019, Acta Diabetologica.

[6]  S. Knorr,et al.  Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview , 2019, Journal of diabetes research.

[7]  V. Dolinsky,et al.  Maternal β-Cell Adaptations in Pregnancy and Placental Signalling: Implications for Gestational Diabetes , 2018, International journal of molecular sciences.

[8]  C. Stehouwer,et al.  Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study , 2018, Endocrine.

[9]  A. Abou-Samra,et al.  Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening , 2018, PloS one.

[10]  M. Rizzo,et al.  Metabolic disorders during pregnancy and postpartum cardiometabolic risk , 2018, Endocrine connections.

[11]  D. Mattson,et al.  The complement system in hypertension and renal damage in the Dahl SS rat , 2018, Physiological reports.

[12]  ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. , 2018, Obstetrics and gynecology.

[13]  E. Kilpatrick,et al.  The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population , 2017, PloS one.

[14]  Farzad Hadaegh,et al.  Screening for Dysglycemia: A Comment on Classification and Diagnosis of Diabetes in American Diabetes Association Standards of Medical Care in Diabetes-2016. , 2017, Archives of Iranian medicine.

[15]  2. Classification and Diagnosis of Diabetes , 2016, Diabetes Care.

[16]  A. Park,et al.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies , 2016, British Medical Journal.

[17]  M. Rahimzadeh,et al.  Regulatory T-cells and preeclampsia: an overview of literature , 2016, Expert review of clinical immunology.

[18]  C. Diéguez,et al.  Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia , 2016, Scientific Reports.

[19]  Cuilin Zhang,et al.  Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective , 2016, Current Diabetes Reports.

[20]  M. Harrison A Global Perspective , 2015, Bulletin of the history of medicine.

[21]  2. Classification and Diagnosis of Diabetes , 2015, Diabetes Care.

[22]  Q. Geng,et al.  Association of Oxidative Stress Biomarkers with Gestational Diabetes Mellitus in Pregnant Women: A Case-Control Study , 2015, PloS one.

[23]  F. Carbone,et al.  The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. , 2014, Immunology letters.

[24]  Tony T. Jiang,et al.  Regulatory T Cells: New Keys for Further Unlocking the Enigma of Fetal Tolerance and Pregnancy Complications , 2014, The Journal of Immunology.

[25]  D. Coustan,et al.  Gestational diabetes mellitus. , 2013, Clinical chemistry.

[26]  J. Sowers,et al.  Gestational Diabetes and the Offspring: Implications in the Development of the Cardiorenal Metabolic Syndrome in Offspring , 2012, Cardiorenal Medicine.

[27]  Y. Dundar,et al.  Overview of the literature , 2012 .

[28]  C. Stehouwer,et al.  Complement C3: an emerging risk factor in cardiometabolic disease , 2012, Diabetologia.

[29]  M. Lappas,et al.  Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[30]  C. Cobelli,et al.  Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy , 2010, Diabetologia.

[31]  Z. Prohászka,et al.  Activation of the complement system in normal pregnancy and preeclampsia. , 2010, Molecular immunology.

[32]  A. Ferrara,et al.  Gestational Weight Gain and Risk of Gestational Diabetes Mellitus , 2010, Obstetrics and gynecology.

[33]  Yuhai Zhao,et al.  Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. , 2009, Journal of inorganic biochemistry.

[34]  A. Blom,et al.  Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack , 2009, Cancer Immunology, Immunotherapy.

[35]  K. Cianflone,et al.  Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes , 2006, International Journal of Obesity.

[36]  R. Romero,et al.  Normal pregnancy is characterized by systemic activation of the complement system , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[37]  J. Fernández-Real,et al.  Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. , 2004, The Journal of clinical endocrinology and metabolism.

[38]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[39]  Gilberto Velho,et al.  Effect of a diabetic environment in utero on predisposition to type 2 diabetes , 2003, The Lancet.

[40]  N. Butte Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. , 2000, The American journal of clinical nutrition.

[41]  L. Herranz,et al.  Early postpartum metabolic assessment in women with prior gestational diabetes. , 1999, Diabetes care.

[42]  J. Manson,et al.  A prospective study of pregravid determinants of gestational diabetes mellitus. , 1997, JAMA.

[43]  L. Notarangelo,et al.  Activity of Classical and Alternative Pathways of Complement in Preterm and Small for Gestational Age Infants , 1984, Pediatric Research.

[44]  P. Lachmann,et al.  The physiological breakdown of the third component of human complement. , 1980, Molecular immunology.

[45]  R. Schreiber,et al.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.